行情

IBIO

IBIO

IBIO
AMEX

实时行情|Nasdaq Last Sale

0.9350
-0.0950
-9.22%
盘前: 0.8602 -0.0748 -8.00% 05:56 04/06 EDT
开盘
1.000
昨收
1.030
最高
1.010
最低
0.9100
成交量
849.66万
成交额
--
52周最高
3.400
52周最低
0.0500
市值
9,485.03万
市盈率(TTM)
-0.6943
分时
5日
1月
3月
1年
5年

EPS

IBIO 新闻

更多
  • IBIO Stock Will Continue to Slide Lower After Speculative COVID-19 Surge
  • InvestorPlace · 2天前
  • 10 Biotech Winners And Losers In Q1
  • Benzinga · 4天前
  • IBio supports AzarGen Bio to develop rituximab biosimilar
  • Seeking Alpha - Article · 03/27 11:24
  • iBio Supporting AzarGen Biotechnologies Development of a Rituximab Biosimilar
  • GlobeNewswire · 03/26 21:20

所属板块

制药
-0.13%
制药与医学研究
-0.22%

热门股票

代码
价格
涨跌幅

IBIO 简况

iBio, Inc. is a biotechnology company. The Company is focused on commercializing its technologies and product candidates and providing product development and manufacturing services to clients and collaborators. Its technologies include iBioLaunch technology and iBioModulator. The Company's technologies constitute a transformative platform for development and production of biologics in hydroponically grown green plants. The Company is focused on the commercialization of its plant-based protein expression technologies for vaccines and therapeutic proteins and on developing and commercializing select biopharmaceutical product candidates. The Company's technology is applicable in a range of product candidates, including products against fibrotic diseases, vaccines, enzyme replacements, monoclonal antibodies, and recombinant versions of marketed products that are derived from human blood plasma.
展开

微牛提供Ibio Inc(AMEX-IBIO)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的IBIO股票新闻,以帮助您做出投资决策。